Skip to main content
SpringerLink
Log in

Epidemiology and Aetiology of Head and Neck Cancers

  • Chapter
  • First Online:
Head and Neck Cancer

Abstract

Malignant neoplasms of the head and neck are among the most common in the world and constitute a major public health problem in most countries. Over 90% of these are squamous cell carcinomas arising in the mucous membranes of the upper aerodigestive tract (UADT). Their epidemiology and aetiology are considered in detail. We separate nasopharyngeal cancer, because it has a specific aetiology related to Epstein-Barr Virus (EBV) infection and dietary carcinogens. We then add those sites with the common major risk factors of alcohol, tobacco (including betel quid/areca nut habits) and diets poor in antioxidants and vitamins, and a minor role for Human Papillomavirus (HPV). Collectively, these UADT sites of oral cavity (including tongue), other pharynx, and larynx have a male incidence/mortality of 15.2/8.1 and for females of 4.6/2.4 cases per 100,000 pa. This ranks UADT cancer as the sixth most common site for men, eighth for women. Adding nasopharynx pushes head and neck cancer higher up the scale. If oesophagus were to be included as another alcohol and tobacco-related cancer, the rates add to 28.6/18.9 and 10.1/6.8 respectively. These cancers – which might be termed cancers of the mouth, throat and gullet – then rank second only to lung cancer in men, and fourth after breast, uterine cervix and large bowel in females, worldwide. Detailed data are presented on geographical, ethnic, gender and time differences. The highest rates in the world are found in Melanesia, South Asia, parts of France, and much of Eastern Europe and the former Soviet republics. Many of these areas are showing rising trends, with a shift to involvement of younger individuals. This, and the fact that survival rates have improved little or not at all in much of the world over several decades, emphasises the need for effective primary and secondary prevention strategies – and for improved public policy to implement these.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 279.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin. 2005;55:74–108.

    PubMed  Google Scholar 

  2. Ferlay J, Bray F, Pisani P, Parkin DM. GLOBOCAN 2002. Cancer Incidence, Mortality and Prevalence Worldwide. IARC Cancer Base No. 5 Version 2.0, 2004.

    Google Scholar 

  3. IARC. Cancer incidence in five continents, vol 1X. Available from: http://www-dep.iarc.fr. Accessed on 10/08/2009.

  4. Moore SR, Johnson NW, Pierce AM, Wilson DF. The epidemiology of mouth cancer: a review of global incidence. Oral Dis. 2000;6:65–74.

    PubMed  CAS  Google Scholar 

  5. Moore SR, Johnson NW, Pierce AM, Wilson DF. The ­epidemiology of tongue cancer: a review of global incidence. Oral Dis. 2000;6:75–84.

    PubMed  CAS  Google Scholar 

  6. Sankaranarayanan R. Oral cancer in India: an epidemiologic and clinical review. Oral Surg Oral Med Oral Pathol. 1990;69:325–30.

    PubMed  CAS  Google Scholar 

  7. World Health Organization. Control of oral cancer in developing countries. A WHO meeting. Bull WHO 1984;62:817–30.

    Google Scholar 

  8. Ministry of Health. National Cancer Control Programme, Sri Lanka. Cancer incidence data: Sri Lanka year 2000. 6th Publication. Maharagama: NCCP; 2005.

    Google Scholar 

  9. Ministry of Health Malaysia. Second report of the National Cancer Registry, Cancer Incidence in Malaysia 2003. Available from http://www.radiologymalaysia.org/Archive/NCR/2ndNCR.pdf. Accessed on 09/12/2009.

  10. Satyanarayana L, Asthana S. Life time risk for development of ten major cancers in India and its trends over the years 1982 to 2000. Indian J Med Sci. 2008;62:35–44.

    PubMed  CAS  Google Scholar 

  11. Gupta PC, Nandakumar A. Oral cancer scene in India. Oral Dis. 1999;5:1–2.

    PubMed  CAS  Google Scholar 

  12. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, et al. Cancer statistics, 2008. CA Cancer J Clin. 2008;58:71–96.

    PubMed  Google Scholar 

  13. Moore SR, Allister J, Roder D, Pierce AM, Wilson DF. Lip cancer in South Australia, 1977–1996. Pathology. 2001;33:167–71.

    PubMed  CAS  Google Scholar 

  14. Nemes JA, Redl P, Boda R, Kiss C, Marton IJ. Oral cancer report from Northeastern Hungary. Pathol Oncol Res. 2008;14:85–92.

    PubMed  Google Scholar 

  15. Tanaka S, Sobue T. Comparison of oral and pharyngeal cancer mortality in five countries: France, Italy, Japan, UK and USA from the WHO Mortality Database (1960–2000). Jpn J Clin Oncol. 2005;35:488–91.

    PubMed  CAS  Google Scholar 

  16. Bosetti C, Bertuccio P, Levi F, Lucchini F, Negri E, La Vecchia C. Cancer mortality in the European Union, 1970–2003, with a joinpoint analysis. Ann Oncol. 2008;19:631–40.

    PubMed  CAS  Google Scholar 

  17. Curado MP, Edwards B, Shin HR, Storm H, Ferlay J, Heanue M, Boyle P. Cancer Incidence in Five Continents, Vol. IX IARC Scientific Publications No. 160, Lyon, IARC;2007. Available from http://www-dep.iarc.fr/. Accessed on 5th January 2010.

  18. Brandizzi D, Chuchurru JA, Lanfranchi HE, Cabrini RL. Analysis of the epidemiological features of oral cancer in the city of Buenos Aires. Acta Odontol Latinoam. 2005;18:31–5.

    PubMed  Google Scholar 

  19. Karim-Kos HE, de Vries E, Soerjomataram I, Lemmens V, Siesling S, Coebergh JW. Recent trends of cancer in Europe: a combined approach of incidence, survival and mortality for 17 cancer sites since the 1990s. Eur J Cancer. 2008;44:1345–89.

    PubMed  Google Scholar 

  20. Conway DI, Stockton DL, Warnakulasuriya KA, Ogden G, Macpherson LM. Incidence of oral and oropharyngeal cancer in United Kingdom (1990–1999) – recent trends and regional variation. Oral Oncol. 2006;42:586–92.

    PubMed  CAS  Google Scholar 

  21. Suba Z. Gender-related hormonal risk factors for oral cancer. Pathol Oncol Res. 2007;13:195–202.

    PubMed  Google Scholar 

  22. Liu L, Kumar SK, Sedghizadeh PP, Jayakar AN, Shuler CF. Oral squamous cell carcinoma incidence by subsite among diverse racial and ethnic populations in California. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2008;105:470–80.

    PubMed  Google Scholar 

  23. Reichman ME, Kelly JJ, Kosary CL, Coughlin SS, Jim MA, Lanier AP. Incidence of cancers of the oral cavity and pharynx among American Indians and Alaska Natives, 1999–2004. Cancer. 2008;113:1256–65.

    PubMed  Google Scholar 

  24. Nichols AC, Bhattacharyya N. Racial differences in stage and survival in head and neck squamous cell carcinoma. Laryngoscope. 2007;117:770–5.

    PubMed  Google Scholar 

  25. Gourin CG, Podolsky RH. Racial disparities in patients with head and neck squamous cell carcinoma. Laryngoscope. 2006;116:1093–106.

    PubMed  Google Scholar 

  26. Suarez E, Calo WA, Hernandez EY, Diaz EC, Figueroa NR, Ortiz AP. Age-standardized incidence and mortality rates of oral and pharyngeal cancer in Puerto Rico and among Non-Hispanics Whites, Non-Hispanic Blacks, and Hispanics in the USA. BMC Cancer. 2009;9:129.

    PubMed  Google Scholar 

  27. Moles DR, Fedele S, Speight PM, Porter SR. dos Santos Silva I. Oral and pharyngeal cancer in South Asians and non-South Asians in relation to socioeconomic deprivation in South East England. Br J Cancer. 2008;98:633–5.

    PubMed  CAS  Google Scholar 

  28. Chhetri DK, Rawnsley JD, Calcaterra TC. Carcinoma of the buccal mucosa. Otolaryngol Head Neck Surg. 2000;123:566–71.

    PubMed  CAS  Google Scholar 

  29. Diaz Jr EM, Holsinger FC, Zuniga ER, Roberts DB, Sorensen DM. Squamous cell carcinoma of the buccal mucosa: one institution’s experience with 119 previously untreated patients. Head Neck. 2003;25:267–73.

    PubMed  Google Scholar 

  30. Iyer SG, Pradhan SA, Pai PS, Patil S. Surgical treatment outcomes of localized squamous carcinoma of buccal mucosa. Head Neck. 2004;26:897–902.

    PubMed  Google Scholar 

  31. Liao CT, Wang HM, Ng SH, Yen TC, Lee LY, Hsueh C, et al. Good tumor control and survivals of squamous cell carcinoma of buccal mucosa treated with radical surgery with or without neck dissection in Taiwan. Oral Oncol. 2006;42:800–9.

    PubMed  Google Scholar 

  32. Lin CS, Jen YM, Cheng MF, Lin YS, Su WF, Hwang JM, et al. Squamous cell carcinoma of the buccal mucosa: an aggressive cancer requiring multimodality treatment. Head Neck. 2006;28:150–7.

    PubMed  Google Scholar 

  33. Sieczka E, Datta R, Singh A, Loree T, Rigual N, Orner J, et al. Cancer of the buccal mucosa: are margins and T-stage accurate predictors of local control? Am J Otolaryngol. 2001;22:395–9.

    PubMed  CAS  Google Scholar 

  34. Surveillance Epidemiology and End Results (SEER). SEER Cancer Statistic Review 1975–2004. National Cancer Institute. Available from: http://seer.cancer.gov/statfacts/html/oralcav.html. Accessed on 10/08/2009.

  35. Llewellyn CD, Johnson NW, Warnakulasuriya KA. Risk factors for squamous cell carcinoma of the oral cavity in young people–a comprehensive literature review. Oral Oncol. 2001;37:401–18.

    PubMed  CAS  Google Scholar 

  36. Warnakulasuriya S, Mak V, Moller H. Oral cancer survival in young people in South East England. Oral Oncol. 2007;43:982–6.

    PubMed  Google Scholar 

  37. Macfarlane GJ, Boyle P, Scully C. Rising mortality from cancer of the tongue in young Scottish males. Lancet. 1987;2:912.

    PubMed  CAS  Google Scholar 

  38. Annertz K, Anderson H, Biorklund A, Moller T, Kantola S, Mork J, et al. Incidence and survival of squamous cell carcinoma of the tongue in Scandinavia, with special reference to young adults. Int J Cancer. 2002;101:95–9.

    PubMed  CAS  Google Scholar 

  39. Schantz SP, Yu GP. Head and neck cancer incidence trends in young Americans, 1973–1997, with a special analysis for tongue cancer. Arch Otolaryngol Head Neck Surg. 2002;128:268–74.

    PubMed  Google Scholar 

  40. Shiboski CH, Schmidt BL, Jordan RC. Tongue and tonsil carcinoma: increasing trends in the U.S. population ages 20–44 years. Cancer. 2005;103:1843–9.

    PubMed  Google Scholar 

  41. Scully C, Bedi R. Ethnicity and oral cancer. Lancet Oncol. 2000;1:37–42.

    PubMed  CAS  Google Scholar 

  42. Robinson KL, Macfarlane GJ. Oropharyngeal cancer incidence and mortality in Scotland: are rates still increasing? Oral Oncol. 2003;39:31–6.

    PubMed  Google Scholar 

  43. Elango JK, Gangadharan P, Sumithra S, Kuriakose MA. Trends of head and neck cancers in urban and rural India. Asian Pac J Cancer Prev. 2006;7:108–12.

    PubMed  Google Scholar 

  44. Llewellyn CD, Johnson NW, Warnakulasuriya KA. Risk factors for oral cancer in newly diagnosed patients aged 45 years and younger: a case-control study in Southern England. J Oral Pathol Med. 2004;33:525–32.

    PubMed  CAS  Google Scholar 

  45. Hirota SK, Braga FP, Penha SS, Sugaya NN, Migliari DA. Risk factors for oral squamous cell carcinoma in young and older Brazilian patients: a comparative analysis. Med Oral Patol Oral Cir Bucal. 2008;13:E227–31.

    PubMed  Google Scholar 

  46. La Vecchia C, Lucchini F, Negri E, Levi F. Trends in oral cancer mortality in Europe. Oral Oncol. 2004;40:433–9.

    PubMed  Google Scholar 

  47. Morse DE, Kerr AR. Disparities in oral and pharyngeal cancer incidence, mortality and survival among black and white Americans. J Am Dent Assoc. 2006;137:203–12.

    PubMed  Google Scholar 

  48. Moore RJ, Doherty DA, Do KA, Chamberlain RM, Khuri FR. Racial disparity in survival of patients with squamous cell carcinoma of the oral cavity and pharynx. Ethn Health. 2001;6:165–77.

    PubMed  CAS  Google Scholar 

  49. Sunny L, Yeole BB, Hakama M, Shiri R, Sastry PS, Mathews S, et al. Oral cancers in Mumbai, India: a fifteen years perspective with respect to incidence trend and cumulative risk. Asian Pac J Cancer Prev. 2004;5:294–300.

    PubMed  Google Scholar 

  50. Amarasinghe HK, Usgodaarachchi US, Johnson NW, Lalloo R, Warnakulasuriya S. Betel-quid chewing with or without tobacco is a major risk factor for oral potentially malignant disorders in Sri Lanka: a case-control study. Oral Oncol. 2010;46(4):297–301.

    PubMed  Google Scholar 

  51. International Agency on Research on Cancer. IARC Monographs on the Evaluation of Carcinogenic Risk to Human. Betel-quid and areca-nut chewing and some areca-nut related nitrosamines. vol.85. Lyon: IARC 2004.

    Google Scholar 

  52. Zaidi JH, Arif M, Fatima I, Qureshi IH. Radiochemical neutron activation analysis for trace elements of basic ingredients of pan. J Radioanal Nucl Chem. 2002;253:459–64.

    CAS  Google Scholar 

  53. Lord GA, Lim CK, Warnakulasuriya S, Peters TJ. Chemical and analytical aspects of areca nut. Addict Biol. 2002;7:99–102.

    PubMed  CAS  Google Scholar 

  54. Nair J, Ohshima H, Nair UJ, Bartsch H. Endogenous formation of nitrosamines and oxidative DNA-damaging agents in tobacco users. Crit Rev Toxicol. 1996;26:149–61.

    PubMed  CAS  Google Scholar 

  55. Carossa S, Pera P, Doglio P, Lombardo S, Colagrande P, Brussino L, et al. Oral nitric oxide during plaque deposition. Eur J Clin Invest. 2001;31:876–9.

    PubMed  CAS  Google Scholar 

  56. Nair U, Bartsch H, Nair J. Alert for an epidemic of oral cancer due to use of the betel quid substitutes gutkha and pan masala: a review of agents and causative mechanisms. Mutagenesis. 2004;19:251–62.

    PubMed  CAS  Google Scholar 

  57. Gupta PC, Warnakulasuriya S. Global epidemiology of areca nut usage. Addict Biol. 2002;7:77–83.

    PubMed  CAS  Google Scholar 

  58. Trivedy CR, Craig G, Warnakulasuriya S. The oral health consequences of chewing areca nut. Addict Biol. 2002;7:115–25.

    PubMed  CAS  Google Scholar 

  59. Shiu MN, Chen TH, Chang SH, Hahn LJ. Risk factors for leukoplakia and malignant transformation to oral carcinoma: a leukoplakia cohort in Taiwan. Br J Cancer. 2000;82:1871–4.

    PubMed  CAS  Google Scholar 

  60. Maher R, Lee AJ, Warnakulasuriya KA, Lewis JA, Johnson NW. Role of areca nut in the causation of oral submucous fibrosis: a case-control study in Pakistan. J Oral Pathol Med. 1994;23:65–9.

    PubMed  CAS  Google Scholar 

  61. Trivedy C, Warnakulasuriya KA, Hazarey VK, Tavassoli M, Sommer P, Johnson NW. The upregulation of lysyl oxidase in oral submucous fibrosis and squamous cell carcinoma. J Oral Pathol Med. 1999;28:246–51.

    PubMed  CAS  Google Scholar 

  62. Thomas SJ, Bain CJ, Battistutta D, Ness AR, Paissat D, Maclennan R. Betel quid not containing tobacco and oral cancer: a report on a case-control study in Papua New Guinea and a meta-analysis of current evidence. Int J Cancer. 2007;120:1318–23.

    PubMed  CAS  Google Scholar 

  63. Subapriya R, Thangavelu A, Mathavan B, Ramachandran CR, Nagini S. Assessment of risk factors for oral squamous cell carcinoma in Chidambaram, Southern India: a case-control study. Eur J Cancer Prev. 2007;16:251–6.

    PubMed  Google Scholar 

  64. van Wyk CW, Stander I, Padayachee A, Grobler-Rabie AF. The areca nut chewing habit and oral squamous cell carcinoma in South African Indians. A retrospective study. S Afr Med J. 1993;83:425–9.

    PubMed  Google Scholar 

  65. Petti S. Lifestyle risk factors for oral cancer. Oral Oncol. 2009;45:340–50.

    PubMed  Google Scholar 

  66. Idris AM, Nair J, Friesen M, Ohshima H, Brouet I, Faustman EM, et al. Carcinogenic tobacco-specific nitrosamines are present at unusually high levels in the saliva of oral snuff users in Sudan. Carcinogenesis. 1992;13:1001–5.

    PubMed  CAS  Google Scholar 

  67. Nair J, Ohshima H, Friesen M, Croisy A, Bhide SV, Bartsch H. Tobacco-specific and betel nut-specific N-nitroso compounds: occurrence in saliva and urine of betel quid chewers and formation in vitro by nitrosation of betel quid. Carcinogenesis. 1985;6:295–303.

    PubMed  CAS  Google Scholar 

  68. Warnakulasuriya S, Sutherland G, Scully C. Tobacco, oral cancer, and treatment of dependence. Oral Oncol. 2005;41:244–60.

    PubMed  Google Scholar 

  69. Gartner C, Hall W. The potential role of snus in tobacco harm reduction. Addiction. 2009;104:1586–7.

    PubMed  Google Scholar 

  70. Haddock CK, Weg MV, DeBon M, Klesges RC, Talcott GW, Lando H, et al. Evidence that smokeless tobacco use is a gateway for smoking initiation in young adult males. Prev Med. 2001;32:262–7.

    PubMed  CAS  Google Scholar 

  71. Critchley JA, Unal B. Health effects associated with smokeless tobacco: a systematic review. Thorax. 2003;58:435–43.

    PubMed  CAS  Google Scholar 

  72. Kallischnigg G, Weitkunat R, Lee PN. Systematic review of the relation between smokeless tobacco and non-neoplastic oral diseases in Europe and the United States. BMC Oral Health. 2008;8:13.

    PubMed  Google Scholar 

  73. IARC Monographs on the Evaluation of Carcinogenic Risk to to Humans, Some Traditional Herbal Medicines, Some Mycotoxins, Naphthalene and Styrene. Vol. 82, Lyon, IARC press. 2002. p. 171–4.

    Google Scholar 

  74. Hecht SS. Tobacco carcinogens, their biomarkers and tobacco-induced cancer. Nat Rev Cancer. 2003;3:733–44.

    PubMed  CAS  Google Scholar 

  75. International Agency for Research on Cancer. Tobacco smoke and involuntary smoking. IARC Monographs on the Evaluation of Carcinogenic Risk to Human. vol.83. Lyon: IARC; 2004.

    Google Scholar 

  76. Zain RB. Cultural and dietary risk factors of oral cancer and ­precancer–a brief overview. Oral Oncol. 2001;37:205–10.

    PubMed  CAS  Google Scholar 

  77. Shah JP, Johnson NW, Batsakis JG. Oral cancer. London/Thieme New York: Martin Dunitz; 2003.

    Google Scholar 

  78. Whent H, Sayers M, Morgan A, Hunt R. Health update Alcohol. 2nd Edition.London. Health Education Authority 1997.

    Google Scholar 

  79. Rehm J. Alcohol consumption and mortality. What do we know and where should we go? Addiction. 2000;95:989–95.

    PubMed  CAS  Google Scholar 

  80. Goldberg DM, Soleas GJ, Levesque M. Moderate alcohol consumption: the gentle face of Janus. Clin Biochem. 1999;32:505–18.

    PubMed  CAS  Google Scholar 

  81. World Health Organization. Department of Mental Health and Substance Abuse. Global status Report on Alcohol 2004.Geneva:WHO 2004.

    Google Scholar 

  82. Institute National Du Cancer. Alcohol and risk of cancer: ≤javascript:void(0)≥ current status of scientific data and recommendations for public health. 2007. Available from http://www.e-cancer.fr/la-sante-publique/prevention/alcoolisme. Accessed on 26/01/2010.

  83. World Health Organization. Evidence for the effectiveness and cost-effectiveness of interventions to reduce alcohol-related harm.Available from ≤http://www.euro.who.int/document/E92823.pdf≥. Accessed on 28/01/2010.

  84. National Health and Medical Research Council. Australian Guidelines to Reduce Health Risk from Drinking Alcohol. Available from http://www.nhmrc.gov.au/_files_nhmrc/file/­publications/synopses/ds10-alcohol.pdf. Accessed on 28/01/2010.

  85. Ogden GR, Wight AJ. Aetiology of oral cancer: alcohol. Br J Oral Maxillofac Surg. 1998;36:247–51.

    PubMed  CAS  Google Scholar 

  86. Howie NM, Trigkas TK, Cruchley AT, Wertz PW, Squier CA, Williams DM. Short-term exposure to alcohol increases the permeability of human oral mucosa. Oral Dis. 2001;7:349–54.

    PubMed  CAS  Google Scholar 

  87. De Stefani E, Boffetta P, Oreggia F, Fierro L, Mendilaharsu M. Hard liquor drinking is associated with higher risk of cancer of the oral cavity and pharynx than wine drinking. A case-control study in Uruguay. Oral Oncol. 1998;34:99–104.

    PubMed  Google Scholar 

  88. Altieri A, Bosetti C, Gallus S, Franceschi S, Dal Maso L, Talamini R, et al. Wine, beer and spirits and risk of oral and pharyngeal cancer: a case-control study from Italy and Switzerland. Oral Oncol. 2004;40:904–9.

    PubMed  Google Scholar 

  89. Elmore JG, Horwitz RI. Oral cancer and mouthwash use: evaluation of the epidemiologic evidence. Otolaryngol Head Neck Surg. 1995;113:253–61.

    PubMed  CAS  Google Scholar 

  90. McCullough MJ, Farah CS. The role of alcohol in oral ­carcinogenesis with particular reference to alcohol-containing mouthwashes. Aust Dent J. 2009;53:302–5.

    Google Scholar 

  91. Guha N, Boffetta P, Wunsch Filho V, Eluf Neto J, Shangina O, Zaridze D, et al. Oral health and risk of squamous cell carcinoma of the head and neck and esophagus: results of two multicentric case-control studies. Am J Epidemiol. 2007;166:1159–73.

    PubMed  Google Scholar 

  92. Young TB, Ford CN, Brandenburg JH. An epidemiologic study of oral cancer in a statewide network. Am J Otolaryngol. 1986;7:200–8.

    PubMed  CAS  Google Scholar 

  93. Winn DM, Diehl SR, Brown LM, Harty LC, Bravo-Otero E, Fraumeni Jr JF, et al. Mouthwash in the etiology of oral cancer in Puerto Rico. Cancer Causes Control. 2001;12:419–29.

    PubMed  CAS  Google Scholar 

  94. La Vecchia C. Mouthwash and oral cancer risk: an update. Oral Oncol. 2009;45:198–200.

    PubMed  Google Scholar 

  95. Warnakulasuriya S. Causes of oral cancer–an appraisal of controversies. Br Dent J. 2009;207:471–5.

    PubMed  CAS  Google Scholar 

  96. Stewart BW, Kleihues P, Stewart Bernard W, Paul K. The cause of cancer In World Cancer Report. Lyon: IARC Press; 2003. p. 22–31.

    Google Scholar 

  97. World Health Organization. Cancer: diet and physical activity’s impact. Available from www.who.int/dietphysicalactivity/­publications/facts/cancer/en. Accessed on 02/02/2010.

  98. De Stefani E, Boffetta P, Ronco AL, Correa P, Oreggia F, Deneo-Pellegrini H, et al. Dietary patterns and risk of cancer of the oral cavity and pharynx in Uruguay. Nutr Cancer. 2005;51:132–9.

    PubMed  Google Scholar 

  99. De Stefani E, Oreggia F, Boffetta P, Deneo-Pellegrini H, Ronco A, Mendilaharsu M. Tomatoes, tomato-rich foods, lycopene and cancer of the upper aerodigestive tract: a case-control in Uruguay. Oral Oncol. 2000;36:47–53.

    PubMed  Google Scholar 

  100. Llewellyn CD, Linklater K, Bell J, Johnson NW, Warnakulasuriya S. An analysis of risk factors for oral cancer in young people: a case-control study. Oral Oncol. 2004;40:304–13.

    PubMed  Google Scholar 

  101. Garavello W, Lucenteforte E, Bosetti C, Talamini R, Levi F, Tavani A, et al. Diet diversity and the risk of laryngeal cancer: a case-control study from Italy and Switzerland. Oral Oncol. 2009;45:85–9.

    PubMed  Google Scholar 

  102. Lucenteforte E, Garavello W, Bosetti C, La Vecchia C. Dietary factors and oral and pharyngeal cancer risk. Oral Oncol. 2009;45:461–7.

    PubMed  CAS  Google Scholar 

  103. Garavello W, Lucenteforte E, Bosetti C, La Vecchia C. The role of foods and nutrients on oral and pharyngeal cancer risk. Minerva Stomatol. 2009;58:25–34.

    PubMed  CAS  Google Scholar 

  104. Levi F, Pasche C, La Vecchia C, Lucchini F, Franceschi S, Monnier P. Food groups and risk of oral and pharyngeal cancer. Int J Cancer. 1998;77:705–9.

    PubMed  CAS  Google Scholar 

  105. Schwartz J, Shklar G. Regression of experimental oral carcinomas by local injection of beta-carotene and canthaxanthin. Nutr Cancer. 1988;11:35–40.

    PubMed  CAS  Google Scholar 

  106. Shklar G, Schwartz JL, Trickler DP, Reid S. Prevention of experimental cancer and immunostimulation by vitamin E (immunosurveillance). J Oral Pathol Med. 1990;19:60–4.

    PubMed  CAS  Google Scholar 

  107. Schwartz JL, Shklar G, Flynn E, Trickler D. The administration of beta carotene to prevent and regress oral carcinoma in the hamster cheek pouch and the associated enhancement of the immune response. Adv Exp Med Biol. 1990;262:77–93.

    PubMed  CAS  Google Scholar 

  108. Warnakulasuriya S. Food, nutrition and oral cancer. In: Michael Wilson, editor. Food constituents and oral health. Woodhead Publishing Limited: Oxford; 2009. p. 273–95.

    Google Scholar 

  109. Pavia M, Pileggi C, Nobile CG, Angelillo IF. Association between fruit and vegetable consumption and oral cancer: a meta-analysis of observational studies. Am J Clin Nutr. 2006;83:1126–34.

    PubMed  CAS  Google Scholar 

  110. Nagao T, Ikeda N, Warnakulasuriya S, Fukano H, Yuasa H, Yano M, et al. Serum antioxidant micronutrients and the risk of oral leukoplakia among Japanese. Oral Oncol. 2000;36:466–70.

    PubMed  CAS  Google Scholar 

  111. Sankaranarayanan R, Mathew B, Varghese C, Sudhakaran PR, Menon V, Jayadeep A, et al. Chemoprevention of oral leukoplakia with vitamin A and beta carotene: an assessment. Oral Oncol. 1997;33:231–6.

    PubMed  CAS  Google Scholar 

  112. Papadimitrakopoulou VA, Lee JJ, William Jr WN, Martin JW, Thomas M, Kim ES, et al. Randomized trial of 13-cis retinoic acid compared with retinyl palmitate with or without beta-carotene in oral premalignancy. J Clin Oncol. 2009;27:599–604.

    PubMed  CAS  Google Scholar 

  113. Tsao AS, Liu D, Martin J, Tang XM, Lee JJ, El-Naggar AK, et al. Phase II randomized, placebo-controlled trial of green tea extract in patients with high-risk oral premalignant lesions. Cancer Prev Res (Phila Pa). 2009;2:931–41.

    CAS  Google Scholar 

  114. Tai J, Yang M, Ni X, Yu D, Fang J, Tan W, et al. Genetic polymorphisms in cytochrome P450 genes are associated with an increased risk of squamous cell carcinoma of the larynx and hypopharynx in a Chinese population. Cancer Genet Cytogenet. 2010;196:76–82.

    PubMed  CAS  Google Scholar 

  115. Handley TP, McCaul JA, Ogden GR. Dyskeratosis congenita. Oral Oncol. 2006;42:331–6.

    PubMed  CAS  Google Scholar 

  116. De Pasquale K, Sataloff RT. Candida of the larynx. Ear Nose Throat J. 2003;82:419.

    PubMed  Google Scholar 

  117. Holmstrup P, Vedtofte P, Reibel J, Stoltze K. Long-term treatment outcome of oral premalignant lesions. Oral Oncol. 2006;42:461–74.

    PubMed  CAS  Google Scholar 

  118. D’Souza G, Kreimer AR, Viscidi R, Pawlita M, Fakhry C, Koch WM, et al. Case-control study of human papillomavirus and oropharyngeal cancer. N Engl J Med. 2007;356:1944–56.

    PubMed  Google Scholar 

  119. Andrews E, Seaman WT, Webster-Cyriaque J. Oropharyngeal carcinoma in non-smokers and non-drinkers: a role for HPV. Oral Oncol. 2009;45:486–91.

    PubMed  Google Scholar 

  120. Meurman JH, Uittamo J. Oral micro-organisms in the etiology of cancer. Acta Odontol Scand. 2008;66:321–6.

    PubMed  Google Scholar 

  121. Homann N, Tillonen J, Rintamaki H, Salaspuro M, Lindqvist C, Meurman JH. Poor dental status increases acetaldehyde production from ethanol in saliva: a possible link to increased oral cancer risk among heavy drinkers. Oral Oncol. 2001;37:153–8.

    PubMed  CAS  Google Scholar 

  122. Wake M. The urban/rural divide in head and neck cancer–the effect of atmospheric pollution. Clin Otolaryngol Allied Sci. 1993;18:298–302.

    PubMed  CAS  Google Scholar 

  123. Sapkota A, Gajalakshmi V, Jetly DH, Roychowdhury S, Dikshit RP, Brennan P, et al. Indoor air pollution from solid fuels and risk of hypopharyngeal/laryngeal and lung cancers: a multicentric case-control study from India. Int J Epidemiol. 2008;37:321–8.

    PubMed  Google Scholar 

  124. Dietz A, Senneweld E, Maier H. Indoor air pollution by emissions of fossil fuel single stoves: possibly a hitherto underrated risk factor in the development of carcinomas in the head and neck. Otolaryngol Head Neck Surg. 1995;112:308–15.

    PubMed  CAS  Google Scholar 

  125. International Agency for Research on Cancer. IARC monographs on the evaluation of the carcinogenic risk of chemicals to humans, Volume 95: Indoor air pollution from heating and cooking: some solid fuels and cooking oil fumes. Lyon: IARC Press; 2006.

    Google Scholar 

  126. Franco EL, Kowalski LP, Oliveira BV, Curado MP, Pereira RN, Silva ME, et al. Risk factors for oral cancer in Brazil: a case-control study. Int J Cancer. 1989;43:992–1000.

    PubMed  CAS  Google Scholar 

  127. Zheng YM, Tuppin P, Hubert A, Jeannel D, Pan YJ, Zeng Y, et al. Environmental and dietary risk factors for nasopharyngeal carcinoma: a case-control study in Zangwu County, Guangxi, China. Br J Cancer. 1994;69:508–14.

    PubMed  CAS  Google Scholar 

  128. Pintos J, Franco EL, Kowalski LP, Oliveira BV, Curado MP. Use of wood stoves and risk of cancers of the upper aero-digestive tract: a case-control study. Int J Epidemiol. 1998;27:936–40.

    PubMed  CAS  Google Scholar 

  129. Baker SR, Krause CJ. Carcinoma of the lip. Laryngoscope. 1980;90:19–27.

    PubMed  CAS  Google Scholar 

  130. Pukkala E, Notkola V. Cancer incidence among Finnish farmers, 1979–1993. Cancer Causes Control. 1997;8:25–33.

    PubMed  CAS  Google Scholar 

  131. Wiklund K, Dich J. Cancer risks among male farmers in Sweden. Eur J Cancer Prev. 1995;4:81–90.

    PubMed  CAS  Google Scholar 

  132. Antoniades DZ, Styanidis K, Papanayotou P, Trigonidis G. Squamous cell carcinoma of the lips in a northern Greek ­population. Evaluation of prognostic factors on 5-year survival rate–I. Eur J Cancer B Oral Oncol. 1995;31B:333–9.

    PubMed  CAS  Google Scholar 

  133. Pukkala E, Soderholm AL, Lindqvist C. Cancers of the lip and oropharynx in different social and occupational groups in Finland. Eur J Cancer B Oral Oncol. 1994;30B:209–15.

    PubMed  CAS  Google Scholar 

  134. Pogoda JM, Preston-Martin S. Solar radiation, lip protection, and lip cancer risk in Los Angeles County women (California, United States). Cancer Causes Control. 1996;7:458–63.

    PubMed  CAS  Google Scholar 

  135. Levi F, La Vecchia C, Te VC, Franceschi S. Trends in lip cancer incidence in Vaud, Switzerland. Br J Cancer. 1993;68:1012–3.

    PubMed  CAS  Google Scholar 

  136. Alho OP, Keranen MR, Kantola S, Riihimaki S, Jokinen K, Alho P, et al. Lip cancer in Northern Finland: changing incidence and clinical characteristics. J Oral Pathol Med. 2000;29:299–302.

    PubMed  CAS  Google Scholar 

  137. Warnakulasuriya S, Johnson NW, van der Waal I. Nomenclature and classification of potentially malignant disorders of the oral mucosa. J Oral Pathol Med. 2007;36:575–80.

    PubMed  CAS  Google Scholar 

  138. van der Waal I. Potentially malignant disorders of the oral and oropharyngeal mucosa; terminology, classification and present concepts of management. Oral Oncol. 2009;45:317–23.

    PubMed  Google Scholar 

  139. Napier SS, Cowan CG, Gregg TA, Stevenson M, Lamey PJ, Toner PG. Potentially malignant oral lesions in Northern Ireland: size (extent) matters. Oral Dis. 2003;9:129–37.

    PubMed  CAS  Google Scholar 

  140. Chung CHYY, Wang TY, Shieh TY, Warnakulasuriya S. Oral precancerous disorders associated with areca quid chewing, smoking, and alcohol drinking in Southern Taiwan. J Oral Pathol Med. 2005;34:460–6.

    PubMed  Google Scholar 

  141. Thomas SJ, Harris R, Ness AR, Taulo J, Maclennan R, Howes N, et al. Betel quid not containing tobacco and oral leukoplakia: a report on a cross-sectional study in Papua New Guinea and a meta-analysis of current evidence. Int J Cancer. 2008;123:1871–6.

    PubMed  CAS  Google Scholar 

  142. Chung CH, Yang YH, Wang TY, Shieh TY, Warnakulasuriya S. Oral precancerous disorders associated with areca quid chewing, smoking, and alcohol drinking in southern Taiwan. J Oral Pathol Med. 2005;34:460–6.

    PubMed  Google Scholar 

  143. Scheifele C, Reichart PA, Dietrich T. Low prevalence of oral leukoplakia in a representative sample of the US population. Oral Oncol. 2003;39:619–25.

    PubMed  Google Scholar 

  144. Ministry of Health. National Oral Health Survey, Sri Lanka (2002/2003). 2009.

    Google Scholar 

  145. Garcia-Pola Vallejo MJ, Martinez Diaz-Canel AI, Garcia Martin JM, Gonzalez GM. Risk factors for oral soft tissue lesions in an adult Spanish population. Community Dent Oral Epidemiol. 2002;30:277–85.

    PubMed  CAS  Google Scholar 

  146. Reichart PA. Oral mucosal lesions in a representative cross-­sectional study of aging Germans. Community Dent Oral Epidemiol. 2000;28:390–8.

    PubMed  CAS  Google Scholar 

  147. Nagao T, Ikeda N, Fukano H, Miyazaki H, Yano M, Warnakulasuriya S. Outcome following a population screening programme for oral cancer and precancer in Japan. Oral Oncol. 2000;36:340–6.

    PubMed  CAS  Google Scholar 

  148. Zain RB, Ikeda N, Razak IA, Axell T, Majid ZA, Gupta PC, et al. A national epidemiological survey of oral mucosal lesions in Malaysia. Community Dent Oral Epidemiol. 1997;25:377–83.

    PubMed  CAS  Google Scholar 

  149. Schepman KP, van der Meij EH, Smeele LE, van der Waal I. Prevalence study of oral white lesions with special reference to a new definition of oral leucoplakia. Eur J Cancer B Oral Oncol. 1996;32B:416–9.

    PubMed  CAS  Google Scholar 

  150. Banoczy J, Rigo O. Prevalence study of oral precancerous lesions within a complex screening system in Hungary. Community Dent Oral Epidemiol. 1991;19:265–7.

    PubMed  CAS  Google Scholar 

  151. Ikeda N, Ishii T, Iida S, Kawai T. Epidemiological study of oral leukoplakia based on mass screening for oral mucosal diseases in a selected Japanese population. Community Dent Oral Epidemiol. 1991;19:160–3.

    PubMed  CAS  Google Scholar 

  152. Axell T, Rundquist L. Oral lichen planus- a demographic study. Community Dent Oral Epidemiol. 1987;15:52–6.

    PubMed  CAS  Google Scholar 

  153. Axell T. Occurrence of leukoplakia and some other oral white lesions among 20, 333 adult Swedish people. Community Dent Oral Epidemiol. 1987;15:46–51.

    PubMed  CAS  Google Scholar 

  154. Petti S. Pooled estimate of world leukoplakia prevalence: a systematic review. Oral Oncol. 2003;39:770–80.

    PubMed  Google Scholar 

  155. Napier SS, Speight PM. Natural history of potentially malignant oral lesions and conditions: an overview of the literature. J Oral Pathol Med. 2008;37:1–10.

    PubMed  Google Scholar 

  156. Reibel J. Prognosis of oral pre-malignant lesions: significance of clinical, histopathological, and molecular biological characteristics. Crit Rev Oral Biol Med. 2003;14:47–62.

    PubMed  Google Scholar 

  157. Pindborg JJ, Mehta FS, Daftary DK. Incidence of oral cancer among 30, 000 villagers in India in a 7-year follow-up study of oral precancerous lesions. Community Dent Oral Epidemiol. 1975;3:86–8.

    PubMed  CAS  Google Scholar 

  158. Silverman Jr S, Gorsky M, Lozada F. Oral leukoplakia and malignant transformation. A follow-up study of 257 patients. Cancer. 1984;53:563–8.

    PubMed  Google Scholar 

  159. Bouquot JE, Kurland LT, Weiland LH. Laryngeal keratosis and carcinoma in the Rochester, MN, population 1935–1984. Cancer Detect Prev. 1991;15:83–91.

    PubMed  CAS  Google Scholar 

  160. Gale N, Michaels L, Luzar B, Poljak M, Zidar N, Fischinger J, et al. Current review on squamous intraepithelial lesions of the larynx. Histopathology. 2009;54:639–56.

    PubMed  Google Scholar 

  161. Vaezi MF, Qadeer MA, Lopez R, Colabianchi N. Laryngeal cancer and gastroesophageal reflux disease: a case-control study. Am J Med. 2006;119:768–76.

    PubMed  Google Scholar 

  162. Bosatra A, Bussani R, Silvestri F. From epithelial dysplasia to squamous carcinoma in the head and neck region: an epidemiological assessment. Acta Otolaryngol Suppl. 1997;527:47–8.

    PubMed  CAS  Google Scholar 

  163. Gallus S, Bosetti C, Franceschi S, Levi F, Negri E, La Vecchia C. Laryngeal cancer in women: tobacco, alcohol, nutritional, and hormonal factors. Cancer Epidemiol Biomark Prev. 2003;12:514–7.

    Google Scholar 

  164. Fiorella R, Di Nicola V, Resta L. Epidemiological and clinical relief on hyperplastic lesions of the larynx. Acta Otolaryngol Suppl. 1997;527:77–81.

    PubMed  CAS  Google Scholar 

  165. Maier H, Tisch M. Epidemiology of laryngeal cancer: results of the Heidelberg case-control study. Acta Otolaryngol Suppl. 1997;527:160–4.

    PubMed  CAS  Google Scholar 

  166. Parnes SM. Asbestos and cancer of the larynx: is there a relationship? Laryngoscope. 1990;100:254–61.

    PubMed  CAS  Google Scholar 

  167. Hobbs CG, Sterne JA, Bailey M, Heyderman RS, Birchall MA, Thomas SJ. Human papillomavirus and head and neck cancer: a systematic review and meta-analysis. Clin Otolaryngol. 2006;31:259–66.

    PubMed  CAS  Google Scholar 

  168. Lewin JS, Gillenwater AM, Garrett JD, Bishop-Leone JK, Nguyen DD, Callender DL, et al. Characterization of laryngopharyngeal reflux in patients with premalignant or early carcinomas of the larynx. Cancer. 2003;97:1010–4.

    PubMed  Google Scholar 

  169. Barnes L, Eveson JW, Reichart P, Sidransky D. World Health Organization classification of tumors:pathology and genetics of head and neck tumours. Lyon: IARC Press; 2005. p. 221–4.

    Google Scholar 

  170. Surgical Pathology of the Salivary Glands. Eds. Ellis, GL, Auclair, PL, Gnepp, DR. Philadelphia, WB Saunders; 1991.

    Google Scholar 

  171. Eisele DW, Johns ME. Salivary Gland Neoplasms. In: Bailey BJ, editor. Head & Neck Surgery-Otolaryngology. Philadelphia: Lippincott Williams & Wilkins; 2001. p. 1279–97.

    Google Scholar 

  172. Kessler A, Handler SD. Salivary gland neoplasms in children: a 10-year survey at the Children’s Hospital of Philadelphia. Int J Pediatr Otorhinolaryngol. 1994;29:195–202.

    PubMed  CAS  Google Scholar 

  173. Lack EE, Upton MP. Histopathologic review of salivary gland tumors in childhood. Arch Otolaryngol Head Neck Surg. 1988;114:898–906.

    PubMed  CAS  Google Scholar 

  174. Seifert G, Okabe H, Caselitz J. Epithelial salivary gland tumors in children and adolescents. Analysis of 80 cases (Salivary Gland Register 1965–1984). ORL J Otorhinolaryngol Relat Spec. 1986;48:137–49.

    PubMed  CAS  Google Scholar 

  175. Shikhani AH, Johns ME. Tumors of the major salivary glands in children. Head Neck Surg. 1988;10:257–63.

    PubMed  CAS  Google Scholar 

  176. Saw D, Lau WH, Ho JH, Chan JK, Ng CS. Malignant lymphoepithelial lesion of the salivary gland. Hum Pathol. 1986;17:914–23.

    PubMed  CAS  Google Scholar 

  177. Tsai CC, Chen CL, Hsu HC. Expression of Epstein-Barr virus in carcinomas of major salivary glands: a strong association with lymphoepithelioma-like carcinoma. Hum Pathol. 1996;27:258–62.

    PubMed  CAS  Google Scholar 

  178. Iezzoni JC, Gaffey MJ, Weiss LM. The role of Epstein-Barr virus in lymphoepithelioma-like carcinomas. Am J Clin Pathol. 1995;103:308–15.

    PubMed  CAS  Google Scholar 

  179. Hamilton-Dutoit SJ, Therkildsen MH, Neilsen NH, Jensen H, Hansen JP, Pallesen G. Undifferentiated carcinoma of the salivary gland in Greenlandic Eskimos: demonstration of Epstein-Barr virus DNA by in situ nucleic acid hybridization. Hum Pathol. 1991;22:811–5.

    PubMed  CAS  Google Scholar 

  180. Martinelli M, Martini F, Rinaldi E, Caramanico L, Magri E, Grandi E, et al. Simian virus 40 sequences and expression of the viral large T antigen oncoprotein in human pleomorphic adenomas of parotid glands. Am J Pathol. 2002;161:1127–33.

    PubMed  CAS  Google Scholar 

  181. Belsky JL, Tachikawa K, Cihak RW, Yamamoto T. Salivary gland tumors in atomic bomb survivors, Hiroshima-Nagasaki, 1957 to 1970. JAMA. 1972;219:864–8.

    PubMed  CAS  Google Scholar 

  182. Belsky JL, Takeichi N, Yamamoto T, Cihak RW, Hirose F, Ezaki H, et al. Salivary gland neoplasms following atomic radiation: additional cases and reanalysis of combined data in a fixed population, 1957–1970. Cancer. 1975;35:555–9.

    PubMed  CAS  Google Scholar 

  183. Saku T, Hayashi Y, Takahara O, Matsuura H, Tokunaga M, Tokuoka S, et al. Salivary gland tumors among atomic bomb survivors, 1950–1987. Cancer. 1997;79:1465–75.

    PubMed  CAS  Google Scholar 

  184. Mihailescu D, Shore-Freedman E, Mukani S, Lubin J, Ron E, Schneider AB. Multiple neoplasms in an irradiated cohort: pattern of occurrence and relationship to thyroid cancer outcome. J Clin Endocrinol Metab. 2002;87:3236–41.

    PubMed  CAS  Google Scholar 

  185. Modan B, Chetrit A, Alfandary E, Tamir A, Lusky A, Wolf M, et al. Increased risk of salivary gland tumors after low-dose irradiation. Laryngoscope. 1998;108:1095–7.

    PubMed  CAS  Google Scholar 

  186. Hoffman DA, McConahey WM, Fraumeni Jr JF, Kurland LT. Cancer incidence following treatment of hyperthyroidism. Int J Epidemiol. 1982;11:218–24.

    PubMed  CAS  Google Scholar 

  187. Preston-Martin S, Thomas DC, White SC, Cohen D. Prior exposure to medical and dental x-rays related to tumors of the parotid gland. J Natl Cancer Inst. 1988;80:943–9.

    PubMed  CAS  Google Scholar 

  188. Preston-Martin S, White SC. Brain and salivary gland tumors related to prior dental radiography: implications for current practice. J Am Dent Assoc. 1990;120:151–8.

    PubMed  CAS  Google Scholar 

  189. Nagler RM, Laufer D. Tumors of the major and minor salivary glands: review of 25 years of experience. Anticancer Res. 1997;17:701–7.

    PubMed  CAS  Google Scholar 

  190. Spitz MR, Sider JG, Newell GR. Salivary gland cancer and risk of subsequent skin cancer. Head Neck. 1990;12:254–6.

    PubMed  CAS  Google Scholar 

  191. Spitz MR, Sider JG, Newell GR, Batsakis JG. Incidence of salivary gland cancer in the United States relative to ultraviolet radiation exposure. Head Neck Surg. 1988;10:305–8.

    PubMed  CAS  Google Scholar 

  192. Miller AS, Harwick RD, Alfaro-Miranda M, Sundararajan M. Search for correlation of radon levels and incidence of salivary gland tumors. Oral Surg Oral Med Oral Pathol. 1993;75:58–63.

    PubMed  CAS  Google Scholar 

  193. Auvinen A, Hietanen M, Luukkonen R, Koskela RS. Brain tumors and salivary gland cancers among cellular telephone users. Epidemiology. 2002;13:356–9.

    PubMed  Google Scholar 

  194. Johansen C, Boice Jr J, McLaughlin J, Olsen J. Cellular telephones and cancer–a nationwide cohort study in Denmark. J Natl Cancer Inst. 2001;93:203–7.

    PubMed  CAS  Google Scholar 

  195. Horn-Ross PL, Ljung BM, Morrow M. Environmental factors and the risk of salivary gland cancer. Epidemiology. 1997;8:414–9.

    PubMed  CAS  Google Scholar 

  196. Milham Jr S. Cancer mortality pattern associated with exposure to metals. Ann NY Acad Sci. 1976;271:243–9.

    PubMed  Google Scholar 

  197. Swanson GM, Belle SH. Cancer morbidity among woodworkers in the U.S. automotive industry. J Occup Med. 1982;24:315–9.

    PubMed  CAS  Google Scholar 

  198. Swanson GM, Burns PB. Cancer incidence among women in the workplace: a study of the association between occupation and industry and 11 cancer sites. J Occup Environ Med. 1995;37:282–7.

    PubMed  CAS  Google Scholar 

  199. Swanson GM, Burns PB. Cancers of the salivary gland: workplace risks among women and men. Ann Epidemiol. 1997;7:369–74.

    PubMed  CAS  Google Scholar 

  200. Graham S, Blanchet M, Rohrer T. Cancer in asbestos-mining and other areas of Quebec. J Natl Cancer Inst. 1977;59:1139–45.

    PubMed  CAS  Google Scholar 

  201. Muscat JE, Wynder EL. A case/control study of risk factors for major salivary gland cancer. Otolaryngol Head Neck Surg. 1998;118:195–8.

    PubMed  CAS  Google Scholar 

  202. Zheng W, Shu XO, Ji BT, Gao YT. Diet and other risk factors for cancer of the salivary glands:a population-based case-control study. Int J Cancer. 1996;67:194–8.

    PubMed  CAS  Google Scholar 

  203. Dietz A, Barme B, Gewelke U, Sennewald E, Heller WD. Maier H [The epidemiology of parotid tumors. A case control study]. HNO. 1993;41:83–90.

    PubMed  CAS  Google Scholar 

  204. Horn-Ross PL, Morrow M, Ljung BM. Diet and the risk of salivary gland cancer. Am J Epidemiol. 1997;146:171–6.

    PubMed  CAS  Google Scholar 

  205. Jeannon JP, Soames JV, Bell H, Wilson JA. Immunohistochemical detection of oestrogen and progesterone receptors in salivary tumours. Clin Otolaryngol Allied Sci. 1999;24:52–4.

    PubMed  CAS  Google Scholar 

  206. Nasser SM, Faquin WC, Dayal Y. Expression of androgen, estrogen, and progesterone receptors in salivary gland tumors. Frequent expression of androgen receptor in a subset of malignant salivary gland tumors. Am J Clin Pathol. 2003;119:801–6.

    PubMed  CAS  Google Scholar 

  207. Fan CY, Melhem MF, Hosal AS, Grandis JR, Barnes EL. Expression of androgen receptor, epidermal growth factor receptor, and transforming growth factor alpha in salivary duct carcinoma. Arch Otolaryngol Head Neck Surg. 2001;127:1075–9.

    PubMed  CAS  Google Scholar 

  208. Chang YM, Barrett JH, Bishop DT, Armstrong BK, Bataille V, Bergman W, et al. Sun exposure and melanoma risk at different latitudes: a pooled analysis of 5700 cases and 7216 controls. Int J Epidemiol. 2009;38:814–30.

    PubMed  Google Scholar 

  209. Meleti M, Leemans CR, Mooi WJ, Vescovi P, van der Waal I. Oral malignant melanoma: a review of the literature. Oral Oncol. 2007;43:116–21.

    PubMed  Google Scholar 

  210. Sasco AJ, Jaquet A, Boidin E, Ekouevi DK, Thouillot F, Lemabec T, et al. The challenge of AIDS-related malignancies in sub-Saharan Africa. PLoS ONE. 2010;5:e8621.

    PubMed  Google Scholar 

  211. Otoh EC, Johnson NW, Mandong BM, Danfillo IS. Primary head and neck cancers in Jos, Nigeria: a re-visit. West Afr J Med. 2006;25:92–100.

    PubMed  CAS  Google Scholar 

  212. Webster-Cyriaque J, Duus K, Cooper C, Duncan M. Oral EBV and KSHV infection in HIV. Adv Dent Res. 2006;19:91–5.

    PubMed  CAS  Google Scholar 

  213. Speicher D, Johnson NW. Improving the Detection of Human herpesvirus-8 in AIDS Patients. In: Rahmatulla M, Shah N, editors. Research Priorities for Meeting Oral Health Goals in Developing Countries. Hyderabad: International Association for Dental Research; Indian Academy for Advanced Dental Education & Paras Medical Books (P) Ltd; 2009. p. 66–79.

    Google Scholar 

  214. Daley TD, Wysocki GP, Pringle GA. Relative incidence of odontogenic tumors and oral and jaw cysts in a Canadian population. Oral Surg Oral Med Oral Pathol. 1994;77:276–80.

    PubMed  CAS  Google Scholar 

  215. Jing W, Xuan M, Lin Y, Wu L, Liu L, Zheng X, et al. Odontogenic tumours: a retrospective study of 1642 cases in a Chinese population. Int J Oral Maxillofac Surg. 2007;36:20–5.

    PubMed  CAS  Google Scholar 

  216. Buchner A, Merrell PW, Carpenter WM. Relative frequency of central odontogenic tumors: a study of 1, 088 cases from Northern California and comparison to studies from other parts of the world. J Oral Maxillofac Surg. 2006;64:1343–52.

    PubMed  Google Scholar 

  217. Smith CJ. Odontogenic Neoplasms and Hamartomas. In: Prabhu R, Wilson DF, Daftary DK, Johnson NW, editors. Chapter 33 in: Oral Diseases in the Tropics. New York: Oxford University Press; 1992.

    Google Scholar 

  218. Ladeinde AL, Ajayi OF, Ogunlewe MO, Adeyemo WL, Arotiba GT, Bamgbose BO, et al. Odontogenic tumors: a review of 319 cases in a Nigerian teaching hospital. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2005;99:191–5.

    PubMed  Google Scholar 

  219. Ogunlewe MO, Ajayi OF, Adeyemo WL, Ladeinde AL, James O. Osteogenic sarcoma of the jaw bones: a single institution experience over a 21-year period. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2006;101:76–81.

    PubMed  Google Scholar 

  220. Fernandes R, Nikitakis NG, Pazoki A, Ord RA. Osteogenic ­sarcoma of the jaw: a 10-year experience. J Oral Maxillofac Surg. 2007;65:1286–91.

    PubMed  Google Scholar 

  221. Hirshberg A, Shnaiderman-Shapiro A, Kaplan I, Berger R. Metastatic tumours to the oral cavity – pathogenesis and analysis of 673 cases. Oral Oncol. 2008;44:743–52.

    PubMed  Google Scholar 

  222. Hirshberg A, Buchner A. Metastatic tumours to the oral region. An overview. Eur J Cancer B Oral Oncol. 1995;31B:355–60.

    PubMed  CAS  Google Scholar 

  223. Hobdell MH, Oliveira ER, Bautista R, Myburgh NG, Lalloo R, Narendran S, et al. Oral diseases and socio-economic status (SES). Br Dent J. 2003;194:91–6. discussion 88.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Griffith Health Institute and School of Dentistry and Oral Health, Griffith University, Building GO5, Room 3.22a, Gold Coast Campus, Gold Coast, Queensland, 4222, Australia

    Newell W. Johnson

Authors
  1. Newell W. Johnson
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hemantha K. Amarasinghe
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Newell W. Johnson .

Editor information

Editors and Affiliations

  1. , Dept of Radio-Oncology, Genolier Swiss Medical Network, 4 Route du Muids, Genolier, CH-1272, Switzerland

    Jacques Bernier

Rights and permissions

Reprints and permissions

Copyright information

© 2011 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Johnson, N.W., Amarasinghe, H.K. (2011). Epidemiology and Aetiology of Head and Neck Cancers. In: Bernier, J. (eds) Head and Neck Cancer. Springer, New York, NY. https://doi.org/10.1007/978-1-4419-9464-6_1

Download citation

  • DOI: https://doi.org/10.1007/978-1-4419-9464-6_1

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4419-9463-9

  • Online ISBN: 978-1-4419-9464-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation